Has Mary Stewart received payments from drug or device companies?

Yes. Drug and device makers reported $9,310 in general payments to Mary Stewart across 386 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Stewart did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Stewart come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Stewart

Hematology & Oncology · Anchorage, AKNPI 1245268002

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 386 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,962 and has fallen 51.9% since, to $1,424 in 2023.

$9,310in general payments, 2019–2025

Across 386 payments — averaging $24.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$939
Johnson & Johnson$643
E.r. Squibb & Sons, L.L.C.$615
Seagen Inc.$447
Astellas Pharma US Inc$435
Pfizer$422
plus $6K from 54 others

What the payments were for

Food & beverage$9,01697%
Education$2943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	37	$939
Johnson & Johnson(2 entities)	36	$643
E.r. Squibb & Sons, L.L.C.	25	$615
Seagen Inc.	19	$447
Astellas Pharma US Inc	12	$435
Pfizer	22	$422
Bristol Myers Squibb	14	$400
Amgen	14	$396
Incyte Corporation	9	$363
Pharmacyclics LLC, An Abbvie Company	12	$350
Sanofi	7	$249
Rigel Pharmaceuticals, Inc.	6	$225
Boehringer Ingelheim	9	$214
Genentech USA, Inc.	14	$208
Coherus Oncology, Inc.	8	$170
Array Biopharma Inc	3	$164
Novartis	8	$163
Merck	6	$155
GSK	8	$152
Eisai Inc.	7	$144
Daiichi Sankyo Inc.	6	$137
Gilead(2 entities)	6	$133
Portola Pharmaceuticals, LLC	2	$131
Octapharma USA, Inc.	2	$129
Bayer	6	$115
EMD Serono, Inc.	6	$114
Clovis Oncology, Inc.	6	$103
Intuitive Surgical	3	$96
AVEO Pharmaceuticals, Inc.	5	$93
Chiesi USA, Inc.	4	$91
Deciphera Pharmaceuticals Inc.	4	$85
AbbVie	4	$83
Jazz Pharmaceuticals Inc.	4	$75
Taiho Oncology, Inc.	3	$68
Regeneron Healthcare Solutions, Inc.	2	$62
Ipsen Biopharmaceuticals, Inc	2	$54
Stemline Therapeutics Inc.	2	$47
Epizyme, Inc.	3	$47
Sanofi-aventis U.S. LLC	2	$45
Adaptive Biotechnologies Corporation	2	$45
Beigene USA, Inc.	2	$43
Spectrum Pharmaceuticals Inc.	2	$42
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Heron Therapeutics, Inc.	2	$40
Blueprint Medicines Corporation	2	$39
Dova Pharmaceuticals	2	$38
Agios Pharmaceuticals, Inc.	2	$38
Servier Pharmaceuticals LLC	2	$37
Myovant Sciences Inc.	2	$36
Pharmaessentia USA Corporation	1	$25
G1 Therapeutics, Inc.	1	$24
Roche Diagnostics Corporation	1	$23
Kyowa Kirin, Inc.	1	$22
Morphosys, US Inc.	1	$22
Sun Pharmaceutical Industries Inc.	1	$22
Sobi, Inc	1	$21
Puma Biotechnology, Inc.	1	$21
Mirati Therapeutics, Inc.	1	$20
Lilly USA, LLC	1	$20
Alnylam Pharmaceuticals Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hematology & oncology providers in Alaskato place this figure against a meaningful peer group, so we don't.

Other hematology & oncology in Anchorage

Steven LiuAnchorage$35K
Max RabinowitzAnchorage$14K
Mary KlixAnchorage$13K
Kendal WebbAnchorage$8K
Natalie WallaceAnchorage$8K
Shannon SmileyAnchorage$6K
Charles BuessAnchorage$5K
Anusiyanthan MariampillaiAnchorage$4K
Theodore KimAnchorage$2K
Ellen ChirichellaAnchorage$1K

See the full list for Alaska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →